An Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 Substrates

Clinical trial NCT06686628 · COMPLETED

Trial details

NCT number: NCT06686628
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Dermatitis Atopic

Start date: 2024-11-20
Primary completion: 2025-11-21
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.